文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在中国,阳性淋巴结比率可预测可手术治疗的胸段食管鳞癌患者的长期生存。

The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.

机构信息

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

出版信息

Ann Surg Oncol. 2013 May;20(5):1653-9. doi: 10.1245/s10434-012-2794-4. Epub 2012 Dec 18.


DOI:10.1245/s10434-012-2794-4
PMID:23247981
Abstract

BACKGROUND: Controversy exists concerning the optimal cutoff points for the positive lymph node ratio (PLNR) to predict overall survival. We aim to propose reasonable PLNR categories for the discrimination of the survival difference between groups. METHODS: We used data from two centers to establish a training (n = 1006) and a validation (n = 783) cohort. All of the patients underwent curative surgical treatment. Martingale residuals from a Cox proportional hazards regression model were used to determine the optimal cutoff points for PLNR to predict overall survival. The survival rate was calculated using the Kaplan-Meier method, and a log-rank test was used to assess the survival differences between groups. The results obtained from the training cohort were tested with the validation cohort at each step. RESULTS: We classified the patients into four revised nodal categories: R-pN0 (PLNR = 0), R-pN1 (0< PLNR ≤0.1), R-pN2 (0.1< PLNR ≤0.3), and R-pN3 (PLNR >0.3). Subgroup analysis for the pT2 and pT3 cases showed that the survival differences could be well discriminated between groups based on PLNR in both the training cohort and validation cohort. When we modified the current staging system using revised nodal categories (based on PLNR) instead of the AJCC nodal categories, the survival rate could also be easily distinguished between patients in different stages in both cohorts of patients. CONCLUSIONS: The survival rate of ESCC can be discriminated between four groups: PLNR = 0, 0< PLNR ≤0.1, 0.1< PLNR ≤0.3, and PLNR >0.3. Further studies are required to confirm these results.

摘要

背景:关于阳性淋巴结比率(PLNR)预测总生存的最佳截断点存在争议。我们旨在提出合理的 PLNR 分类,以区分组间生存差异。

方法:我们使用来自两个中心的数据建立了一个训练(n = 1006)和一个验证(n = 783)队列。所有患者均接受根治性手术治疗。使用 Cox 比例风险回归模型的 Martingale 残差来确定 PLNR 预测总生存的最佳截断点。使用 Kaplan-Meier 方法计算生存率,并使用对数秩检验评估组间生存差异。在每个步骤中,我们都使用验证队列测试从训练队列获得的结果。

结果:我们将患者分为四个修订的淋巴结分类:R-pN0(PLNR = 0)、R-pN1(0<PLNR ≤0.1)、R-pN2(0.1<PLNR ≤0.3)和 R-pN3(PLNR >0.3)。对于 pT2 和 pT3 病例的亚组分析表明,基于 PLNR,在训练队列和验证队列中,都可以很好地区分组间的生存差异。当我们使用修订的淋巴结分类(基于 PLNR)而不是 AJCC 淋巴结分类修改当前分期系统时,在两个患者队列中,不同分期的患者的生存率也可以很容易地区分。

结论:ESCC 的生存率可以分为四组:PLNR = 0、0<PLNR ≤0.1、0.1<PLNR ≤0.3 和 PLNR >0.3。需要进一步的研究来证实这些结果。

相似文献

[1]
The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.

Ann Surg Oncol. 2012-12-18

[2]
Modification of nodal categories in the seventh american joint committee on cancer staging system for esophageal squamous cell carcinoma in Chinese patients.

Ann Thorac Surg. 2011-7

[3]
Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.

Ann Thorac Surg. 2012-5-1

[4]
Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell Carcinoma.

Oncol Res Treat. 2015-8-18

[5]
Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.

Ann Thorac Surg. 2009-7

[6]
[Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].

Zhonghua Wei Chang Wai Ke Za Zhi. 2011-9

[7]
[Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].

Zhonghua Zhong Liu Za Zhi. 2007-8

[8]
[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].

Zhonghua Zhong Liu Za Zhi. 2009-7

[9]
Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients.

Ann Surg Oncol. 2014-1

[10]
Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Am J Surg. 2005-1

引用本文的文献

[1]
Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma.

Transl Cancer Res. 2025-1-31

[2]
Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.

BMC Cancer. 2024-10-29

[3]
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma.

NPJ Precis Oncol. 2024-1-30

[4]
The value of lymph nodes ratios in the prognosis of resectable remnant gastric cancer through the retrospective propensity score matching analysis.

World J Surg Oncol. 2023-8-11

[5]
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.

Front Oncol. 2022-11-10

[6]
Number of Positive Lymph Nodes Combined with the Logarithmic Ratio of Positive Lymph Nodes predicts Survival in Patients with Non-Metastatic Larynx Squamous Cell Carcinoma.

J Cancer. 2022-3-14

[7]
Positive lymph node ratio as a novel indicator of prognosis in gastric signet ring cell carcinoma: a population-based retrospective study.

Transl Cancer Res. 2020-5

[8]
Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal.

Gastroenterol Res Pract. 2021-4-3

[9]
The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

In Vivo. 2020

[10]
Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Int J Clin Exp Pathol. 2020-3-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索